TWI844795B - 自噬活化劑 - Google Patents

自噬活化劑 Download PDF

Info

Publication number
TWI844795B
TWI844795B TW110134884A TW110134884A TWI844795B TW I844795 B TWI844795 B TW I844795B TW 110134884 A TW110134884 A TW 110134884A TW 110134884 A TW110134884 A TW 110134884A TW I844795 B TWI844795 B TW I844795B
Authority
TW
Taiwan
Prior art keywords
gene
autophagy
tocopherol
tocopherol phosphate
disease
Prior art date
Application number
TW110134884A
Other languages
English (en)
Chinese (zh)
Other versions
TW202228715A (zh
Inventor
中上夕子
Original Assignee
日商力森諾科股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商力森諾科股份有限公司 filed Critical 日商力森諾科股份有限公司
Publication of TW202228715A publication Critical patent/TW202228715A/zh
Application granted granted Critical
Publication of TWI844795B publication Critical patent/TWI844795B/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/665Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW110134884A 2020-09-17 2021-09-17 自噬活化劑 TWI844795B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020156458 2020-09-17
JP2020-156458 2020-09-17

Publications (2)

Publication Number Publication Date
TW202228715A TW202228715A (zh) 2022-08-01
TWI844795B true TWI844795B (zh) 2024-06-11

Family

ID=80776075

Family Applications (1)

Application Number Title Priority Date Filing Date
TW110134884A TWI844795B (zh) 2020-09-17 2021-09-17 自噬活化劑

Country Status (5)

Country Link
JP (1) JPWO2022059767A1 (https=)
KR (1) KR20230051262A (https=)
CN (1) CN116507314A (https=)
TW (1) TWI844795B (https=)
WO (1) WO2022059767A1 (https=)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1723019A (zh) * 2003-01-17 2006-01-18 生命健康科学有限公司 具有抗增殖属性的化合物
WO2020090881A1 (ja) * 2018-11-02 2020-05-07 昭和電工株式会社 水中油滴型皮膚外用剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1589964B1 (en) * 2003-01-17 2011-11-23 Vital Health Sciences Pty Ltd. Compounds having anti-proliferative properties
WO2013018779A1 (ja) 2011-08-01 2013-02-07 株式会社林原 α-グルコシルヘスペリジンの結晶とその用途
KR20170141705A (ko) 2015-04-08 2017-12-26 바이오멘딕스, 엘엘씨 상처 치유를 조절하기 위한 제형 및 방법
JP6740354B2 (ja) 2015-10-05 2020-08-12 ザ トラスティーズ オブ コロンビア ユニバーシティー イン ザ シティー オブ ニューヨーク オートファジーの流れ及びホスホリパーゼd及びタウを含むタンパク質凝集体のクリアランスの活性化剤ならびにタンパク質症の治療方法
JP7136765B2 (ja) 2017-03-24 2022-09-13 株式会社林原 オートファジー誘導剤とその用途
JP7399406B2 (ja) * 2019-03-04 2023-12-18 公立大学法人横浜市立大学 精子形成誘導用培地
JP7497850B2 (ja) * 2019-12-23 2024-06-11 株式会社アイ・ティー・オー 細胞送達用キャリア

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1723019A (zh) * 2003-01-17 2006-01-18 生命健康科学有限公司 具有抗增殖属性的化合物
WO2020090881A1 (ja) * 2018-11-02 2020-05-07 昭和電工株式会社 水中油滴型皮膚外用剤

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
期刊 , A GUGLIANDOLO, et al., "α-Tocopherol modulates non-amyloidogenic pathway and autophagy in an in vitro model of Alzheimer's disease: A transcriptional study", Brain Sci., 9, MDPI, 2019: 196. *

Also Published As

Publication number Publication date
WO2022059767A1 (ja) 2022-03-24
JPWO2022059767A1 (https=) 2022-03-24
KR20230051262A (ko) 2023-04-17
CN116507314A (zh) 2023-07-28
TW202228715A (zh) 2022-08-01

Similar Documents

Publication Publication Date Title
JP2011246442A (ja) 光老化抑制剤および皮膚菲薄化抑制剤
CN1984637A (zh) 包含芍药甙的皮肤老化护理品
JP5893013B2 (ja) 光曝露による皮膚細胞異常化の抑制剤
TWI844795B (zh) 自噬活化劑
JP2005535717A (ja) フィトスフィンゴシン誘導体を含むアポトーシス誘導用組成物
JP7619529B2 (ja) 水系組成物、及び皮膚外用剤
JP7361448B2 (ja) トランスグルタミナーゼ発現促進剤
CN116322705B (zh) 自噬激活剂
WO2008041608A1 (fr) Préparation externe cutanée et produit de soin capillaire
CN116782910A (zh) 屏障功能改善剂
TW202228676A (zh) 自噬活化劑
JP6368219B2 (ja) エストロゲン受容体β活性化剤
JPWO2022168846A5 (https=)
JP2022119110A (ja) バリア機能改善剤
JP2017088559A (ja) フィラグリン産生促進剤
US20230364119A1 (en) Autophagy activator
WO2014073646A1 (ja) シコニン誘導体を有するペリオスチンの発現抑制剤
KR101984276B1 (ko) 베르베린 하이드로클로라이드를 유효성분으로 포함하는 체모성장 저해용 조성물
WO2020230726A1 (ja) 大気汚染物質からの保護剤及び大気汚染物質からの保護用組成物
JP2020193182A (ja) 糖化反応抑止剤
WO2025094676A1 (ja) 1-ピペリジンプロピオン酸とゲンノショウコとを含む組成物
KR20160133044A (ko) 클로린 e6을 포함하는 아토피 피부염 예방 및 치료용 조성물
KR20250089445A (ko) Yap 억제제를 유효성분으로 포함하는 아토피성 피부염의 예방 또는 치료용 약학 조성물
KR20150051075A (ko) 팔마틴을 유효성분으로 포함하는 체모성장 저해용 조성물
CN115297866A (zh) 变性弹性蛋白的分解降低的抑制剂、正常的弹性蛋白纤维的维持剂、弹性蛋白-抑弹性蛋白酶蛋白复合体形成抑制剂及含有这些的组合物